2. Academic Validation
  3. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors

Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors

  • Bioorg Med Chem Lett. 2004 Oct 18;14(20):5171-4. doi: 10.1016/j.bmcl.2004.07.061.
Masahiro Tanaka 1,  Shoichi Sagawa,  Jun-ichi Hoshi,  Fumito Shimoma,  Isamu Matsuda,  Kenji Sakoda,  Tomohiko Sasase,  Masanori Shindo,  Takashi Inaba
Affiliations

Affiliation

  • 1 Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.
PMID: 15380221 DOI: 10.1016/j.bmcl.2004.07.061
Abstract

We report herein synthesis of PKCbeta-selective inhibitors possessing the novel pharmacophore of anilino-monoindolylmaleimide. Several compounds of this series exhibited IC50's as low as 50 nM against human PKCbeta2. One of the most potent compounds, 6l, inhibited PKCbeta1 and PKCbeta2 with IC50 of 21 and 5 nM, respectively, and exhibited selectivity of more than 60-fold in favor of PKCbeta2 relative to Other PKC isozymes (PKCalpha, PKCgamma, and PKCepsilon).

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验，部分功能也使用 Cookies 帮助我们更好地理解您的需求，为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问，请阅读我们的《隐私声明》。

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z